Please Wait...

LitTRACE: Simplified Tracking and Assessment of Safety-Related Literature

The scientific literature has always been a very dependable source of information for identifying drug safety-related information, such as Individual Case Safety Reports (ICSRs), signals, aggregate report relevant information and epidemiology data. Tracking this safety information is mandated by regulatory agencies. Relevant safety information published in national and international journals, including that from local journals, conferences and symposia, are considered for assessment. The manual process of sifting through individual articles and journals, tracking the information and record keeping requires considerable time and resources.

At Bioclinica, we strive to streamline the time-consuming, resource-intensive, but critical, tasks for your literature review activities, freeing up resources to concentrate on medical analyses and relevance assessments. With LitTRACE, we aimed to create a user-friendly, fully-customizable and semi-automated literature assessment and tracking tool to help monitor safety and to meet the associated regulatory requirements. And, we think that we succeeded.

This enables timely access to reliable and consolidated information pertaining to adverse event reporting and product benefit risk evaluation from the literature that you can use for clinical evaluations, pre-market approvals and adverse events reporting. The LitTRACE tool also creates databases for ICSRs and similar compliance reports.

What sets LitTRACE apart? It serves as a central repository for weekly hits and full-text articles, as well as associated workflows.

Set-up and Configuration

Workflow Tools

Outputs

Fully configurable for each client’s unique requirements

Role assignment for literature review or assessment

Standard and configurable reporting

Flexible folder structure in which you can build multiple folders based on product or therapeutic areas

Full audit trail, including date and time of report requests

Data can be pulled for any timeframe

Direct data import from third-party sources such as EMBASE, PubMed, Ovid or EMA medical literature monitoring (MLM).

User reports

Facilitates signal detection

Hosted in your company environment or at BioClinica

E2B XML generation for integration with ArisG/Argus.

Facilitates aggregate reports or risk minimization plan

 

Therefore, LitTRACE is a one-stop solution for performing regular literature assessment for all company medicinal products; requesting, collating and archiving full-text articles; performing translation; and generating automated reports of records (weekly, monthly, annual and customized) at any given time point. This helps with documentation and audit preparedness in compliance with health authority (FDA, EMEA and other global regulatory bodies) requirements.

While its main purpose is currently for literature reviews, we also see the potential for LitTRACE to play a role in signal detection, aggregate reporting and risk minimization plans.

If you have any questions about LitTRACE, I'd be happy to talk with you. Feel free to reach out to me in an email at nirathi.prasanna@bioclinica.com.

LitTrace and PVTrace Overview Sheet

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

A great resource for Alzheimers's research teams. https://t.co/qhVP6ImwoO
bioclinica (12 hours ago)
RT @bioclinica: #Pharmacovigilance: Get up-to-speed on latest ind. trends & best practices + hear how others R meeting today's most pressin…
bioclinica (13 hours ago)
RT @Xtalks: Trends in #Pharmacovigilance – Market Research and Future Impact This webinar will discuss an overview of key findings within r…
bioclinica (13 hours ago)
RT @IntClinTrials: Patient loss and can reduced by introducing new methods during the follow-up period. Martin Collyer at @bioclinica tells…
bioclinica (13 hours ago)
@bioclinica experts talk candidly about #Alzheimer's research & where improvements can be made. Joyce Suhy, Marieke… https://t.co/u1Wmu41jRr
bioclinica (13 hours ago)
RT @ACROhealth: @MaryWolleyRA Mary Woolley @ResearchAmerica: 80% have heard of #clinicaltrials. 75% think trial participation is as importa…
bioclinica (1 week ago)

Latest Blogs:

Latin America: Benefit from the Right Partner
Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen